Ligand Pharmaceuticals
LGND
#3617
Rank
S$4.80 B
Marketcap
S$244.37
Share price
-1.57%
Change (1 day)
53.24%
Change (1 year)

Earnings for Ligand Pharmaceuticals (LGND)

Earnings in 2025 (TTM): S$80.67 Million

According to Ligand Pharmaceuticals's latest financial reports the company's current earnings are S$0.25 Billion. In 2024 the company made an earning of S$7.06 Million a decrease over its 2023 earnings that were of S$81.81 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ligand Pharmaceuticals from 1994 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) S$80.67 M1042.47%
2024 S$7.06 M-91.37%
2023 S$81.81 M-7.59%
2022 S$88.53 M4%
2021 S$85.13 M296.42%
2020 S$21.47 M-97.97%
2019 S$1.05 B275.62%
2018 S$0.28 B237.48%
2017 S$83.53 M49.05%
2016 S$56.04 M55.41%
2015 S$36.06 M36.87%
2014 S$26.34 M29.59%
2013 S$20.33 M1309.35%
2012 S$1.44 M-43.97%
2011 S$2.57 M-113.19%
2010 -S$19.53 Million59.86%
2009 -S$12.22 Million-61.33%
2008 -S$31.58 Million-58.75%
2007 -S$76.55 Million20.52%
2006 -S$63.52 Million81.27%
2005 -S$35.04 Million
2003 -S$24.4 Million-20.6%
2002 -S$30.73 Million4.38%
2001 -S$29.44 Million-48.83%
2000 -S$57.52 Million-19.74%
1999 -S$71.67 Million-19.06%
1998 -S$88.54 Million126.71%
1997 -S$39.06 Million-5.83%
1996 -S$41.48 Million136.23%
1995 -S$17.56 Million-33.97%
1994 -S$26.59 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$41.21 B 48,402.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$15.07 B 17,644.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$28.62 B 33,591.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$10.48 B 12,242.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-S$0.35 Billion-504.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$29.37 B 34,469.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$10.21 B 11,926.71%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$11.85 B 13,857.90%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
-S$78.72 Million-192.65%๐Ÿ‡บ๐Ÿ‡ธ USA